세계의 동물용 구충제 시장 : 유형별, 동물 유형별, 적용 형태별, 기생충 유형별, 유통 채널별, 최종사용자별 - 예측(2025-2030년)

The Veterinary Parasiticides Market was valued at USD 8.21 billion in 2024 and is projected to grow to USD 8.83 billion in 2025, with a CAGR of 7.78%, reaching USD 12.87 billion by 2030.

The veterinary parasiticides market is undergoing a profound transformation as a result of evolving disease patterns, innovations in drug formulations, and rising awareness about animal health. In today's highly competitive environment, the need for effective parasitic control is paramount for both companion animals and livestock. This summary outlines the current state of the market while shedding light on the factors that are driving its evolution.

Modern veterinary practices have increasingly adopted advanced parasiticide solutions to address both conventional and emerging parasitic challenges. As the industry grows, professionals are required to balance traditional treatments with novel approaches. Progressive regulatory frameworks and heightened animal welfare standards have provided impetus for the development of safer, more efficient agents. Meanwhile, the integration of technology within animal health management has led to improved diagnostic tools and better delivery mechanisms.

These developments, coupled with a strong focus on research and sustainability, have reshaped market dynamics, ensuring that stakeholders are better equipped than ever before to tackle complex parasitic infestations. Looking ahead, this environment of change presents both challenges and significant opportunities for innovation in treatment and delivery that harness the full potential of advanced parasiticide therapies.

Transformative Shifts in the Parasiticides Market Landscape

The landscape of veterinary parasiticides has experienced transformative shifts driven by rapid innovation, evolving customer demands, and regulatory influences. Market participants are now reimagining their strategies to meet the dual challenges of emerging parasitic resistance and shifting demographics of animal ownership. Advanced research in pharmacology has facilitated the development of formulations that not only enhance efficacy but also improve safety profiles, thereby aligning with stricter compliance standards.

Concurrently, there has been a notable shift towards precision medicine in animal health, which emphasizes personalized treatment plans and a more effective use of resources in combating parasitic infestations. This paradigm shift is fostering a new era of integrated health management solutions that combine high-quality parasiticides with complementary health products and diagnostic technologies. The industry is increasingly investing in digital platforms and artificial intelligence to streamline distribution and enhance customer engagement, paving the way for quicker adoption of innovative therapies.

In addition, global markets are witnessing the influence of progressive regulatory policies which are intended to maintain the highest safety standards while promoting competitive innovation. As decision-makers recalibrate their business models, they are embracing collaborative research initiatives and seeking partnerships that align technological innovation with sustainable growth. This dynamic environment not only fuels competition but also fuels the momentum for continuous market expansion and enhanced therapeutic outcomes.

Key Segmentation Insights Driving Market Dynamics

The veterinary parasiticides market is intricately segmented, offering a multifaceted understanding of consumer needs and therapeutic applications that drive market dynamics. One dimension of the market is studied based on type, where products are categorized as ectoparasiticides, endectocides, and endoparasiticides. Each subset addresses unique parasitic challenges and is formulated to cater to specific parasitic behaviors.

Another important dimension involves segmentation based on animal type, which distinguishes between companion animals and livestock. Companion animals, which include birds, cats, dogs, and reptiles, require specialized formulations that are often different from those used in livestock. The latter, comprising cattle, poultry, sheep and goats, and swine, typically demands a broad-spectrum approach that can effectively address the diverse parasitic challenges encountered in larger scale animal husbandry.

Further segmentation is conducted on the basis of mode of application, delineating treatments into injectable, oral, and topical administrations. This categorization reflects the need for tailor-made solutions depending on the severity of infestation and the administration capabilities of veterinary practitioners. In addition, another segmentation focuses on the type of parasite addressed, including cestodes, ectoparasites, nematodes, and trematodes, which enables targeted therapeutic strategies.

Market distribution also plays a critical role, with channels divided into offline and online retail that shape product accessibility and customer behavior. Finally, segmentation based on the end-user covers animal farms, household pet owners, and veterinary hospitals, wherein animal farms are further dissected into dairy, poultry, and swine farms, reflecting the complex purchasing behaviors and diverse needs of different customer segments. Together, these segmentation insights offer a comprehensive view of market demand and highlight opportunities for innovation and specialized product development.

Based on Type, market is studied across Ectoparasiticides, Endectocides, and Endoparasiticides.

Based on Animal Type, market is studied across Companion Animals and Livestock Animals. The Companion Animals is further studied across Birds, Cats, Dogs, and Reptiles. The Livestock Animals is further studied across Cattle, Poultry, Sheep & Goats, and Swine.

Based on Mode Of Application, market is studied across Injectable Administration, Oral Administration, and Topical Administration.

Based on Parasite Type, market is studied across Cestodes, Ectoparasites, Nemotodes, and Trematodes.

Based on Distribution Channel, market is studied across Offline Retail and Online Retail.

Based on End-User, market is studied across Animal Farms, Household Pet Owners, and Veterinary Hospitals. The Animal Farms is further studied across Dairy Farms, Poultry Farms, and Swine Farms.

Regional Market Trends and Strategic Insights

A regional analysis of the veterinary parasiticides market reveals distinctive trends and strategic insights that underscore the diversity of demand across different geographies. In the Americas, a combination of advanced animal healthcare infrastructure and a widespread focus on livestock productivity has driven significant demand for high efficacy and cutting-edge parasiticide solutions. Stakeholders in this region continue to invest in research programs and adopt regulatory practices that encourage innovation and improved animal welfare standards.

In the combined region of Europe, Middle East, and Africa, regulatory landscapes are evolving to meet the twin objectives of market competitiveness and environmental sustainability. Here, premium quality products that are aligned with stringent safety norms offer considerable growth potential. Awareness about zoonotic diseases and the role of parasitic control in ensuring food security is also catalyzing product enhancements and strategic partnerships.

The Asia-Pacific region, on the other hand, presents unique challenges and opportunities driven by rapid urbanization, a rising pet ownership trend, and the dominance of agriculture-based economies. This region is characterized by robust demand for both conventional treatments and emerging advanced parasiticide formulations, driven by improved distribution networks and an increasingly informed consumer base. Overall, these regional insights call for a strategic approach that embraces local market dynamics while leveraging global best practices to secure a competitive edge.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Shaping the Veterinary Parasiticides Industry

The market is notably influenced by a host of key companies that are setting benchmarks in innovation and quality. Industry leaders such as AB Vista Inc. and Alltech Inc. have firmly established their presence by investing in robust research and development platforms that consistently deliver high-performing products. Companies like Ashish Life Science Pvt Limited and Aurora Pharmaceutical, Inc. continue to push the envelope with novel formulations, ensuring competitive advantage through advanced applications of biotechnology.

Established giants such as Bayer AG and Merck & Co., Inc. bring decades of expertise and a global operational footprint, which have continuously contributed to shaping market trends and setting rigorous quality standards. The contributions of firms like Bimeda Inc., Bioiberica, S.A., and Boehringer Ingelheim International GmbH have been vital in offering integrated therapeutic solutions designed for both companion animals and livestock.

Other notable entities including Cargill Inc., Ceva Sante Animale, and Covetrus Inc. have intensified market competitiveness by tailoring their portfolios to meet diverse regional and demographic requirements. Companies such as Dechra Pharmaceuticals Plc, Elanco Animal Health Incorporated, and Indian Immunologicals Limited continue to define industry benchmarks through their relentless pursuit of efficacy in parasiticides. Additionally, mid-sized firms like Jurox Animal Health Ltd., Neogen Corporation, and Norbrook Laboratories Ltd. have emerged as key players in specialized niches. Firms including PetIQ, LLC, Vetaid Animal Health, VetGuard Inc., along with Vetoquinol S.A. and Vetsafe Ltd., further complement the industry fabric, creating an ecosystem that fosters innovation, reliability, and strategic growth. Finally, as Virbac Corporation, Zhejiang Hisun Pharmaceutical Co., Ltd., and Zoetis Inc. drive forward globalization and advanced application methods, their influence remains a testament to the market's dynamic evolution.

The report delves into recent significant developments in the Veterinary Parasiticides Market, highlighting leading vendors and their innovative profiles. These include AB Vista Inc., Alltech Inc., Ashish Life Science Pvt Limited, Aurora Pharmaceutical, Inc., Bayer AG, Bimeda Inc., Bioiberica, S.A., Boehringer Ingelheim International GmbH, Cargill Inc., Ceva Sante Animale, Covetrus Inc., Dechra Pharmaceuticals Plc, Elanco Animal Health Incorporated, Indian Immunologicals Limited, Jurox Animal Health Ltd., Merck & Co., Inc., Neogen Corporation, Norbrook Laboratories Ltd., PetIQ, LLC, Vetaid Animal Health, VetGuard Inc., Vetoquinol S.A., Vetsafe Ltd., Virbac Corporation, Zhejiang Hisun Pharmaceutical Co., Ltd., and Zoetis Inc.. Actionable Recommendations for Market Leaders

For industry leaders navigating the evolving veterinary parasiticides landscape, a multi-pronged strategic approach is essential to capture emerging opportunities while mitigating potential risks. It is advisable for decision-makers to ramp up investment in research and development in order to foster product innovation. Developing more targeted parasiticide solutions that address specific parasitic challenges can aid in maintaining a competitive edge.

Leaders should also consider forming strategic collaborations and partnerships that bridge research institutions and technology providers, thereby enhancing the efficacy and safety of newer therapeutic compounds. Embracing digital transformation to optimize supply chain operations and improve customer engagement further consolidates market position. In an era where precision medicine and individualized treatment plans are becoming the norm, leveraging data analytics to better understand customer behaviors and regional demand will be vital.

Furthermore, it is imperative for companies to remain agile in response to evolving regulatory standards by implementing robust compliance frameworks. Proactive investment in staff training and in the development of digital tools for monitoring product performance and safety will help ensure that companies remain at the forefront of the market. Ultimately, by aligning innovative product development with robust operational strategies and strategic regional positioning, market leaders can unlock sustained growth and improved therapeutic outcomes across the veterinary parasiticides arena.

Conclusion: Strategic Outlook and Future Directions

In summary, the veterinary parasiticides market is marked by a dynamic interplay of innovation, regulatory evolution, and diverse consumer needs. The in-depth examination of various segmentation dimensions reveals a complex but highly promising environment where targeted product development and technological integration play crucial roles. Regions across the globe, from the Americas to Asia-Pacific, exhibit unique market dynamics that necessitate tailored strategies to maximize therapeutic efficacy and commercial success.

Key companies continue to set high standards in research and application, driving the market toward more refined and efficient parasiticide solutions. As industry trends shift towards precision medicine and digital integration, stakeholders must be prepared to adapt quickly and proactively. The market's future will be shaped by the continued evolution of regulatory landscapes and the successful integration of advanced technologies in both product development and distribution. Leading industry participants are, therefore, encouraged to adopt a forward-thinking mindset, recognizing that innovation and collaboration are the cornerstones for sustainable growth in this competitive sector.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rise in zoonotic diseases globally
    • 5.1.1.2. Growing inclination toward preventive healthcare practices for pets
    • 5.1.1.3. Expansion of parasitic research and development activities worldwide
  • 5.1.2. Restraints
    • 5.1.2.1. Complexities in the manufacturing and distribution of parasiticides
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements in formulations for improved product development of veterinary parasiticides
    • 5.1.3.2. Expansion of distribution channels for parasiticides
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns regarding safety and efficacy of parasiticides
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product Type: Significant adoption of ectoparasiticides for fast-acting delivery systems
  • 5.2.2. End User: The growing integration of rapid-acting parasiticide drugs for dairy farms and pet animals
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Veterinary Parasiticides Market, by Type

• 6.1. Introduction
• 6.2. Ectoparasiticides
• 6.3. Endectocides
• 6.4. Endoparasiticides

7. Veterinary Parasiticides Market, by Animal Type

• 7.1. Introduction
• 7.2. Companion Animals
  • 7.2.1. Birds
  • 7.2.2. Cats
  • 7.2.3. Dogs
  • 7.2.4. Reptiles
• 7.3. Livestock Animals
  • 7.3.1. Cattle
  • 7.3.2. Poultry
  • 7.3.3. Sheep & Goats
  • 7.3.4. Swine

8. Veterinary Parasiticides Market, by Mode Of Application

• 8.1. Introduction
• 8.2. Injectable Administration
• 8.3. Oral Administration
• 8.4. Topical Administration

9. Veterinary Parasiticides Market, by Parasite Type

• 9.1. Introduction
• 9.2. Cestodes
• 9.3. Ectoparasites
• 9.4. Nemotodes
• 9.5. Trematodes

10. Veterinary Parasiticides Market, by Distribution Channel

• 10.1. Introduction
• 10.2. Offline Retail
• 10.3. Online Retail

11. Veterinary Parasiticides Market, by End-User

• 11.1. Introduction
• 11.2. Animal Farms
  • 11.2.1. Dairy Farms
  • 11.2.2. Poultry Farms
  • 11.2.3. Swine Farms
• 11.3. Household Pet Owners
• 11.4. Veterinary Hospitals

12. Americas Veterinary Parasiticides Market

• 12.1. Introduction
• 12.2. Argentina
• 12.3. Brazil
• 12.4. Canada
• 12.5. Mexico
• 12.6. United States

13. Asia-Pacific Veterinary Parasiticides Market

• 13.1. Introduction
• 13.2. Australia
• 13.3. China
• 13.4. India
• 13.5. Indonesia
• 13.6. Japan
• 13.7. Malaysia
• 13.8. Philippines
• 13.9. Singapore
• 13.10. South Korea
• 13.11. Taiwan
• 13.12. Thailand
• 13.13. Vietnam

14. Europe, Middle East & Africa Veterinary Parasiticides Market

• 14.1. Introduction
• 14.2. Denmark
• 14.3. Egypt
• 14.4. Finland
• 14.5. France
• 14.6. Germany
• 14.7. Israel
• 14.8. Italy
• 14.9. Netherlands
• 14.10. Nigeria
• 14.11. Norway
• 14.12. Poland
• 14.13. Qatar
• 14.14. Russia
• 14.15. Saudi Arabia
• 14.16. South Africa
• 14.17. Spain
• 14.18. Sweden
• 14.19. Switzerland
• 14.20. Turkey
• 14.21. United Arab Emirates
• 14.22. United Kingdom

15. Competitive Landscape

• 15.1. Market Share Analysis, 2024
• 15.2. FPNV Positioning Matrix, 2024
• 15.3. Competitive Scenario Analysis
  • 15.3.1. European approval of BRAVECTO TriUNO marks Merck Animal Health's strategic expansion into comprehensive canine parasiticide solutions
  • 15.3.2. Elanco secures FDA approval for Credelio Quattro, a comprehensive monthly parasiticide that safeguards dogs
  • 15.3.3. Zoetis collaborates with BVNA to enhance veterinary nurse expertise through targeted parasiticide CPD and comprehensive educational initiatives
• 15.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AB Vista Inc.
• 2. Alltech Inc.
• 3. Ashish Life Science Pvt Limited
• 4. Aurora Pharmaceutical, Inc.
• 5. Bayer AG
• 6. Bimeda Inc.
• 7. Bioiberica, S.A.
• 8. Boehringer Ingelheim International GmbH
• 9. Cargill Inc.
• 10. Ceva Sante Animale
• 11. Covetrus Inc.
• 12. Dechra Pharmaceuticals Plc
• 13. Elanco Animal Health Incorporated
• 14. Indian Immunologicals Limited
• 15. Jurox Animal Health Ltd.
• 16. Merck & Co., Inc.
• 17. Neogen Corporation
• 18. Norbrook Laboratories Ltd.
• 19. PetIQ, LLC
• 20. Vetaid Animal Health
• 21. VetGuard Inc.
• 22. Vetoquinol S.A.
• 23. Vetsafe Ltd.
• 24. Virbac Corporation
• 25. Zhejiang Hisun Pharmaceutical Co., Ltd.
• 26. Zoetis Inc.